Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy

Different factors are used as predictors of unfavorable clinical outcomes in B-Cell Acute Lymphoblastic Leukemia (B-ALL) patients. However, new prognostic markers are needed in order to allow treatment to be more accurate, providing better results and an improved quality of life. In the present stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Marlon Wendell Athaydes, Magalhães-Gama, Fábio, Ibiapina, Hiochelson Najibe Santos, Hanna, Fabíola Silva Alves, Xabregas, Lilyane Amorim, Alves, Eliana Brasil, Pimentel, João Paulo Diniz, Carvalho, Maria Perpétuo Socorro Sampaio, Tarragô, Andréa Monteiro, Teixeira-Carvalho, Andréa, Martins-Filho, Olindo Assis, da Costa, Allyson Guimarães, Malheiro, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503185/
https://www.ncbi.nlm.nih.gov/pubmed/34646761
http://dx.doi.org/10.3389/fonc.2021.696032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503185/
https://www.ncbi.nlm.nih.gov/pubmed/34646761
http://dx.doi.org/10.3389/fonc.2021.696032

Ejemplares similares